Header Logo

Connection

JOSEPH KHOURY to Treatment Outcome

Back to Details
This is a "connection" page, showing publications JOSEPH KHOURY has written about Treatment Outcome.
JOSEPH KHOURY
Connection Strength
0.505
Treatment Outcome
  1. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia. Am J Surg Pathol. 2020 09; 44(9):1235-1243.
    View in: PubMed
    Score: 0.041
  2. Myeloid diseases in the lung and pleura. Semin Diagn Pathol. 2020 Nov; 37(6):296-302.
    View in: PubMed
    Score: 0.040
  3. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma. Am J Surg Pathol. 2018 04; 42(4):492-499.
    View in: PubMed
    Score: 0.034
  4. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm. Am J Hematol. 2017 Jun; 92(6):520-528.
    View in: PubMed
    Score: 0.032
  5. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016 Apr 14; 127(15):1863-9.
    View in: PubMed
    Score: 0.029
  6. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol. 2015 Jun 10; 8:65.
    View in: PubMed
    Score: 0.028
  7. Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia. J Hematol Oncol. 2014 Mar 27; 7:26.
    View in: PubMed
    Score: 0.026
  8. Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the F?d?ration Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems. Cancer. 2010 May 01; 116(9):2266-74.
    View in: PubMed
    Score: 0.020
  9. Ewing sarcoma-family tumors that arise after treatment of primary childhood cancer. Cancer. 2006 Jul 01; 107(1):201-6.
    View in: PubMed
    Score: 0.015
  10. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2005 Mar 15; 103(6):1317-8; author reply 1318.
    View in: PubMed
    Score: 0.014
  11. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3692-9.
    View in: PubMed
    Score: 0.013
  12. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation. Ann Diagn Pathol. 2022 Feb; 56:151860.
    View in: PubMed
    Score: 0.011
  13. Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):338-344.
    View in: PubMed
    Score: 0.010
  14. Valve surgery for infective endocarditis complicated by stroke: surgical timing and perioperative neurological complications. Eur J Neurol. 2020 12; 27(12):2430-2438.
    View in: PubMed
    Score: 0.010
  15. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas. Curr Hematol Malig Rep. 2020 08; 15(4):372-381.
    View in: PubMed
    Score: 0.010
  16. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol. 2020 03; 33(3):324-333.
    View in: PubMed
    Score: 0.009
  17. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv. 2019 07 09; 3(13):2035-2039.
    View in: PubMed
    Score: 0.009
  18. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leuk Lymphoma. 2019 10; 60(10):2432-2440.
    View in: PubMed
    Score: 0.009
  19. A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leuk Lymphoma. 2019 09; 60(9):2207-2213.
    View in: PubMed
    Score: 0.009
  20. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):447-455.
    View in: PubMed
    Score: 0.009
  21. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk. 2019 04; 19(4):244-250.
    View in: PubMed
    Score: 0.009
  22. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Cancer. 2018 10 15; 124(20):4044-4055.
    View in: PubMed
    Score: 0.009
  23. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement. Aesthet Surg J. 2018 Jun 13; 38(7).
    View in: PubMed
    Score: 0.009
  24. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 2018 02; 19(2):240-248.
    View in: PubMed
    Score: 0.008
  25. Sporadic Burkitt Lymphoma Presenting as Intestinal Polyposis in a Child. Appl Immunohistochem Mol Morphol. 2017 10; 25(9):e80-e81.
    View in: PubMed
    Score: 0.008
  26. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer. 2017 Oct 01; 123(19):3717-3724.
    View in: PubMed
    Score: 0.008
  27. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma. Am J Hematol. 2017 06; 92(6):E114-E117.
    View in: PubMed
    Score: 0.008
  28. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):333-338.
    View in: PubMed
    Score: 0.008
  29. Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents. Cancer. 2017 Feb 15; 123(4):629-637.
    View in: PubMed
    Score: 0.008
  30. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol. 1996 Jan; 17(1):79-85.
    View in: PubMed
    Score: 0.007
  31. Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms. AJNR Am J Neuroradiol. 2016 May; 37(5):849-55.
    View in: PubMed
    Score: 0.007
  32. Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement. Blood. 2013 Nov 07; 122(19):3387-8.
    View in: PubMed
    Score: 0.006
  33. Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2011 Jan; 35(1):70-5.
    View in: PubMed
    Score: 0.005
  34. Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer. 2007 Dec; 49(7):906-8.
    View in: PubMed
    Score: 0.004
  35. MRI and biologic behavior of desmoid tumors in children. AJR Am J Roentgenol. 2007 Sep; 189(3):633-40.
    View in: PubMed
    Score: 0.004
  36. St. Jude Children's Research Hospital, Memphis, Tennessee: gestational choriocarcinoma. Pediatr Blood Cancer. 2006 Oct 15; 47(5):640-6.
    View in: PubMed
    Score: 0.004
  37. Osteosarcoma among children aged 5 years or younger: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol. 2006 Jan; 28(1):43-7.
    View in: PubMed
    Score: 0.004
  38. Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. AJNR Am J Neuroradiol. 2001 Apr; 22(4):685-90.
    View in: PubMed
    Score: 0.003
  39. Bizarre parosteal osteochondromatous proliferation of bone (BPOP): an unusual foot mass in a child. Foot Ankle Int. 2000 May; 21(5):404-7.
    View in: PubMed
    Score: 0.002
  40. Ragweed immunotherapy in adult asthma. N Engl J Med. 1996 Feb 22; 334(8):501-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.